Although both those cell lines are MYCN amplified, Kelly is derived from primary neuroblastoma while SK-N-BE(2)-C from metastatic site (bone marrow); therefore, more aggressive SK-N-BE(2)-C may be more resistant to verlindamycin-induced apoptosis. The gene discussed is MYCN; the disease is neuroblastoma.